Trulieve Cannabis (FRA:T0A) Marketable Securities: €0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T0A Trulieve Cannabis Corp FRA:T0A
65 GF Score
Price €7.73
GF Value €5.33
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Trulieve Cannabis Marketable Securities?

Trulieve Cannabis FRA:T0A 65 Marketable Securities is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:T0A with a GF Score™ of 65/100 and a GF Value™ of €5.33 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Trulieve Cannabis's Marketable Securities for the quarter that ended in Jun. 2026 was €0.0 Mil.

Trulieve Cannabis's annual Marketable Securities increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€57.7 Mil) but then declined from Dec. 2024 (€57.7 Mil) to Dec. 2025 (€0.0 Mil).

Trulieve Cannabis  (FRA:T0A) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Trulieve Cannabis Marketable Securities Related Terms

Trulieve Cannabis Marketable Securities Historical Data

* Premium members only.

The historical data trend for Trulieve Cannabis's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trulieve Cannabis Marketable Securities Chart

Trulieve Cannabis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 57.68 0.00

Trulieve Cannabis Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:T0A
65GF Score
Trulieve Cannabis Corp FRA:T0A
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trulieve Cannabis Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.0 Mil mean?
Trulieve Cannabis (FRA:T0A) has a Marketable Securities of €0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Trulieve Cannabis and its competitors.
Is Trulieve Cannabis' Marketable Securities too high?
Trulieve Cannabis' current Marketable Securities is €0.0 Mil. Overall, Trulieve Cannabis has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Marketable Securities compare to ANIP and XERS?
Trulieve Cannabis' Marketable Securities of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Trulieve Cannabis and its competitors. Trulieve Cannabis's current Marketable Securities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (FRA:T0A) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.33, compared to a current price of €7.73 — trading 45% above its estimated fair value. The current Marketable Securities is €0.0 Mil. Trulieve Cannabis' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Trulieve Cannabis (FRA:T0A), the current Marketable Securities is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trulieve Cannabis (FRA:T0A) Overvalued in 2026?

Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued. The current stock price of €7.73 is trading 45% above its estimated GF Value™ of €5.33. GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.

Key valuation signals for FRA:T0A:

  • Marketable Securities: €0.0 Mil
  • GF Value™: €5.33 vs. price of €7.73 (45% above fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the FRA:T0A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trulieve Cannabis Business Description

Address 3494 Martin Hurst Road, Tallahassee, FL, USA, 32312
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
65GF Score

Get the complete analysis for FRA:T0A

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.73
Price
€5.33
GF Value